| Description | Trelagliptin succinate (SYR-472 succinate) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D). |
| Target activity | DPP4:4 nM |
| Synonyms | 曲格列汀琥珀酸盐, 琥珀酸曲格列汀, SYR-472 succinate, SYR472 |
| molecular weight | 475.47 |
| Molecular formula | C22H26FN5O6 |
| CAS | 1029877-94-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 55 mg/mL (115.67 mM) |
| References | 1. McKeage K. Drugs. 2015 Jul;75(10):1161-4.2. Inagaki N, et al. Lancet Diabetes Endocrinol. 2015 Mar;3(3):191-7. |